ASP4901 + Tamsulosin + Placebo

Phase 2Completed
0 watching 0 views this week Active
52
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Benign Prostate Hyperplasia

Conditions

Benign Prostate Hyperplasia

Trial Timeline

Jul 22, 2013 → Apr 4, 2014

About ASP4901 + Tamsulosin + Placebo

ASP4901 + Tamsulosin + Placebo is a phase 2 stage product being developed by Astellas Pharma for Benign Prostate Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT02038868. Target conditions include Benign Prostate Hyperplasia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02038868Phase 2Completed

Competing Products

20 competing products in Benign Prostate Hyperplasia

See all competitors